Intellipharmaceutics International Inc(IPCIF)

Description: Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; and Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression. It also provides Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Pristiq, a desvenlafaxine extended-release tablet to treat depression; and Regabatin and Lyrica, a pregabalin extended-release capsule for the management of neuropathic pain. In addition, the company offers Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, it is developing Oxycodone ER, an extended release tablet for relief of pain. The company has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.

---

Keywords: Pharmaceutical Drugs Pain Diabetes Euphoriants Psychoactive Drugs Chemical Compounds Hypertension Schizophrenia Depression Heart Failure Epilepsy Drug Delivery Systems Bipolar Disorder Hyperactivity Disorder Methylphenidate Stimulants Treatment Of Schizophrenia Quetiapine Seroquel Xr Ranexa Chronic Angina Dexmethylphenidate Gastroesophageal Reflux Disease Hypermatrix Technology Nootropics Phenethylamines Venlafaxine

---

Home Page: www.intellipharmaceutics.com

30 Worcester Road
Toronto, ON M9W 5X2
Canada
Phone: 416 798 3001

---

Officers

Exchange: OTCQB

Country: US

Currency: US Dollar ($)